Actively Recruiting
Reach Through Equitable Implementation in Utah (REI-UT) to Increase Tobacco Quit Services Access and Address Social Health Needs
Led by University of Utah · Updated on 2025-03-18
1560
Participants Needed
1
Research Sites
10 weeks
Total Duration
On this page
Sponsors
U
University of Utah
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating ways to increase the reach of proven tobacco cessation programs and reduce the impact of social factors affecting health among patients in safety-net healthcare systems who live in areas of persistent poverty. This pragmatic, multilevel Type III Hybrid Effectiveness-Implementation trial includes exploring various clinic and patient-level strategies to improve access to tobacco quit services and support related social needs. The study also aims to understand how different clinic and patient characteristics influence these efforts and to assess the cost-effectiveness of these strategies. The trial uses a clinic-level implementation strategy called Ask-Advise-Connect (AAC), which integrates electronic health record prompts to identify tobacco use and social health needs and refer patients to resources. Patients who do not enroll in the Utah Tobacco and Nicotine Quit Services within four weeks of a clinic visit will be randomly assigned to one of 20 patient-level intervention groups. These groups vary by whether they receive bundled or non-bundled outreach addressing tobacco cessation and social needs, the type of patient navigation support (reactive or proactive), and the number of proactive outreach opportunities via a conversational agent over 12 months. Participants will have recent clinic visits, be adults who currently use tobacco and live in poverty-affected areas, and have a valid cell phone number for text communication. Researchers will track enrollment in quit services and use of social support resources up to 12 months after enrollment. Outcomes measured include reach of tobacco quit services, social needs service reach, patient engagement, abstinence, and cost-effectiveness. The study runs through January 2028 and includes monitoring through electronic health records and patient interactions over the study period.
CONDITIONS
Brief Title
Reach Through Equitable Implementation in Utah
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least 18 years of age
- Speak English or Spanish
- Currently use tobacco
- Live in a persistent poverty census tract
- Have had a recent visit at a participating clinic
- Have a valid cell phone number listed in the electronic health record
- Have not opted out of receiving text contact from the clinic
You will not qualify if you...
- Opted out of the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - Ongoing from initial clinic visit
Participants receive clinic-based support through the Ask-Advise-Connect (AAC) strategy, which helps assess tobacco use and social health needs using electronic health record tools.
No specific visits required for participants
Duration - Up to 12 months following the initial clinic visit
Participants who do not enroll in Quit Services within 4 weeks after their clinic visit are randomized to receive one of multiple patient-level outreach strategies. These include proactive or reactive contact from patient navigators and varied numbers of outreach opportunities via a conversational agent to support tobacco quit services and address social health needs.
Up to 4 proactive calls from a patient navigator and 1 to 12 outreach opportunities via conversational agent over 12 months, with additional contact available upon participant request
Trial Site Locations
Total: 1 location
1
Huntsman Cancer Institute at the University of Utah
Salt Lake City, Utah, United States, 84112
Actively Recruiting
Research Team
C
Chelsey Schlechter, PhD
C
Chelsey Schlechter, MPH, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
PREVENTION
Number of Arms
21
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here